Enhancement of Doxorubicin Cytotoxicity by Verapamil in Human Breast Cancer Cells
Sameer E. Al-harthy, Mashael S. Al-Motairi, Huda M. Al-Kreathy, Fatemah O. Kamel, Mohamed M. Sayed-Ahmed, Etimad Abbas Huwait, Hamdan S. Al-Malkey & Abdel-Moneim M. Osman · Journal of Pharmaceutical Research International · 2019
Background: Worldwide, breast cancer is a main cause of morbidity and mortality in females. Doxorubicin (DOX) is an anthracycline anticancer drug and most commonly employed in polychemotherapy protocols in the treatment of solid and hematological tumors. Unfortunately, its optima...
Open access
Research Article
10.9734/jpri/2019/v27i630188